Status:
UNKNOWN
Stent Placement and the Risk of New-onset AF in Patients With AMI
Lead Sponsor:
Mackay Memorial Hospital
Conditions:
Atrial Fibrillation New Onset
Acute Myocardial Infarction
Eligibility:
All Genders
20+ years
Brief Summary
The benefit of a drug-eluting stent (DES) in patients with acute myocardial infarction (AMI) is controversial. This study will aim to observe the effect of a DES on the risk of new-onset AF in patient...
Detailed Description
Acute myocardial infarction (AMI) is the leading cause of mortality in the world. Early invasive strategy with percutaneous coronary intervention (PCI) has been demonstrated to be the most effective s...
Eligibility Criteria
Inclusion
- Patients were enrolled by primary diagnostic coding as acute myocardial infarction and treatment coding as receiving PCI between 2007 and 2013 in Taiwan National Health Insurance Research Database (NHIRD)
Exclusion
- Less than 20-years-old; Unknown sex and age
- Not residents in Taiwan
- Died during AMI admission
- Previous history of AF
- Receiving coronary artery bypass grafting (CABG), ventricular assist device (VAD), extracorporeal membrane oxygenation (ECMO), and heart transplantation during observational and/or database period
- No stent implantation during PCI
- Unknown stent types
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
40000 Patients enrolled
Trial Details
Trial ID
NCT03382990
Start Date
January 1 2018
End Date
December 31 2019
Last Update
December 26 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.